SYNEDGEN, INC.

Profile

Company Names

SYNEDGEN, INC.

Addresses

1420 N. CLAREMONT BOULEVARD, SUITE 105D, CLAREMONT, CA 91711

1420 CLAREMONT BOULEVARD, SUITE 105D, CLAREMONT, CA 91711

Phone Numbers

909-447-6858

 

Entity Type:

CORPORATION

Industry:

PHARMACEUTICALS, BIOTECHNOLOGY

Year Incorporated:

2009

State Incorporated:

DELAWARE

Total Amount Raised:

$24,336,397.00

Number of Funding Rounds:

8
Investment Rounds
Round #
Round Open Date
Amount Raised
Total Round Size
Amount Remaining to be Raised
Securities
8
2024-09-11 
$1,750,000.00 
$2,000,000.00 
$250,000.00 
Debt 
7
2019-06-30 
$2,500,000.00 
$3,000,000.00 
$500,000.00 
 
6
2017-08-30 
$3,000,000.00 
$3,000,000.00 
$0.00 
Debt 
5
2016-10-28 
$3,000,000.00 
$3,500,000.00 
$500,000.00 
Debt 
4
2016-04-13 
$6,000,000.00 
$6,500,000.00 
$500,000.00 
 
3
2015-02-24 
$3,500,000.00 
$4,000,000.00 
$500,000.00 
Equity 
2
2014-08-07 
$607,440.00 
$607,440.00 
$0.00 
Equity 
1
2009-10-10 
$3,978,957.00 
$4,000,000.00 
$21,043.00 
Equity 
People
First Name
Middle Name
Last Name
Titles
Related Companies
CLARKE 
 
ATWELL 
DIRECTOR
SHENDA 
 
BAKER 
EXECUTIVE OFFICER, DIRECTOR
DANIEL 
 
BRADBURY 
DIRECTOR
ROBERT 
 
COUGHLIN 
DIRECTOR
KEIKI-PUA 
 
DANCIL 
EXECUTIVE OFFICER
KENTON 
 
GREGORY 
DIRECTOR
KENTON 
 
GREGORY, M.D. 
DIRECTOR
PAUL 
C. 
GRINT 
DIRECTOR
PAUL 
 
GRINT, M.D. 
DIRECTOR
ANDREW 
W. 
MILLER 
DIRECTOR
HAL 
 
OIEN 
DIRECTOR
DIANE 
 
OLMSTEAD 
DIRECTOR
KAVERI 
 
PARKER 
EXECUTIVE OFFICER
LARRY 
 
SHAPIRO 
DIRECTOR
WILLIAM 
 
WEISMANN 
EXECUTIVE OFFICER, DIRECTOR
WILLIAM 
 
WIESMANN 
EXECUTIVE OFFICER, DIRECTOR
WILLIAM 
P. 
WIESMANN 
EXECUTIVE OFFICER, DIRECTOR
WILLIAM 
P. 
WIESMANN, M.D. 
EXECUTIVE OFFICER, DIRECTOR
Filings
Filing Date
Filing Type
Source URL
Industry Classifier
Detailed Industry
Revenue Range
Securities
First Sale Date
D
PHARMACEUTICALS 
 
DECLINE TO DISCLOSE 
Debt 
2024-09-11 
D
PHARMACEUTICALS 
 
DECLINE TO DISCLOSE 
 
2019-06-30 
D
PHARMACEUTICALS 
 
DECLINE TO DISCLOSE 
Debt 
2017-08-30 
D
PHARMACEUTICALS 
 
DECLINE TO DISCLOSE 
Debt 
2016-10-28 
D
PHARMACEUTICALS 
 
DECLINE TO DISCLOSE 
 
2016-04-13 
D
PHARMACEUTICALS 
 
DECLINE TO DISCLOSE 
Equity 
2015-02-24 
D
PHARMACEUTICALS 
 
DECLINE TO DISCLOSE 
Equity 
2014-08-07 
D/A
PHARMACEUTICALS 
 
DECLINE TO DISCLOSE 
Equity 
2009-10-10 
D/A
PHARMACEUTICALS 
 
DECLINE TO DISCLOSE 
Equity 
2009-10-10 
D/A
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Equity 
2009-10-10 
D/A
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Equity 
2009-10-10 
D/A
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Equity 
2009-10-10 
D/A
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Equity 
2009-10-10 
D/A
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Equity 
2009-10-10 
D
BIOTECHNOLOGY 
 
$1 - $1,000,000 
Equity 
2009-10-10 
Brokers
Broker Dealer
Broker CRD#
Recipient Name
Recipient CRD#